Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gibson

Showing results (611-620 of 737) with videos related to

Pageof 74
Sort By:
Oncogene|September 21, 2002
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavageAndrea H Bild, Francisco J Mendoza, Erika M Gibson, et al.
Clinical and Experimental Immunology|December 17, 2008
An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammationS Hutchison, B S W Choo-Kang, V B Gibson, et al.
The American Journal of Managed Care|May 18, 2010
Cost burden of treatment resistance in patients with depressionTeresa B Gibson, Yonghua Jing, Ginger Smith Carls, et al.
Journal of Dental Research|January 19, 2022
Consensus Statement on Future Directions for the Behavioral and Social Sciences in Oral HealthD W McNeil, C L Randall, S Baker, et al.
Thrombosis and Haemostasis|August 26, 1998
Human parvovirus B19 infection in persons with haemophiliaC Prowse, B Dow, S J Pelly, et al.
Journal of Cellular and Molecular Medicine|May 23, 2008
Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathwaySaeid Ghavami, Ahmad Asoodeh, Thomas Klonisch, et al.
Cancer Biology & Therapy|October 16, 2015
Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cellsYongqiang Chen, Elizabeth S Henson, Wenyan Xiao, et al.
Blood Advances|February 19, 2025
ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cellsSara E F Kost, Ali Saleh, Jennifer Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancyH F Sims, J C Brackett, C K Powell, et al.
Neurology|May 13, 2016
Population-based risks for cancer in patients with ALSSummer B Gibson, Diana Abbott, James M Farnham, et al.
Pageof 74

Showing results (611-620 of 737) with videos related to

Sort By:
Pageof 74
Oncogene|September 21, 2002
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavageAndrea H Bild, Francisco J Mendoza, Erika M Gibson, et al.
Clinical and Experimental Immunology|December 17, 2008
An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammationS Hutchison, B S W Choo-Kang, V B Gibson, et al.
The American Journal of Managed Care|May 18, 2010
Cost burden of treatment resistance in patients with depressionTeresa B Gibson, Yonghua Jing, Ginger Smith Carls, et al.
Journal of Dental Research|January 19, 2022
Consensus Statement on Future Directions for the Behavioral and Social Sciences in Oral HealthD W McNeil, C L Randall, S Baker, et al.
Thrombosis and Haemostasis|August 26, 1998
Human parvovirus B19 infection in persons with haemophiliaC Prowse, B Dow, S J Pelly, et al.
Journal of Cellular and Molecular Medicine|May 23, 2008
Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathwaySaeid Ghavami, Ahmad Asoodeh, Thomas Klonisch, et al.
Cancer Biology & Therapy|October 16, 2015
Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cellsYongqiang Chen, Elizabeth S Henson, Wenyan Xiao, et al.
Blood Advances|February 19, 2025
ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cellsSara E F Kost, Ali Saleh, Jennifer Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancyH F Sims, J C Brackett, C K Powell, et al.
Neurology|May 13, 2016
Population-based risks for cancer in patients with ALSSummer B Gibson, Diana Abbott, James M Farnham, et al.
Pageof 74